Get startedLog in
    Picture of Rhythm Pharmaceuticals logo

    RYTM — Rhythm Pharmaceuticals News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousLarge CapHigh Flyer
    All News

    Rhythm Pharmaceuticals' drug for rare obesity disorder meets main goal in late-stage trial

    Picture of Rhythm Pharmaceuticals logoRhythm Pharmaceuticals
    07/04/2025 12:09
    April 7 (Reuters) - Rhythm Pharmaceuticals RYTM.O said on Monday that its experimental drug to treat a rare obesity disorder met the main goal in a late-stage trial.

 (Reporting by Sneha  S K; Editing by Vijay Kishore)

 ((Sneha.SK@thomsonreuters.com;))

    Recent news on Rhythm Pharmaceuticals

    See all news